Eye Infections, Fungal: Clinical Trials

3 trials for Eye Infections, Fungal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 11Completed 1
Phase 21Completed 1

Follow Eye Infections, Fungal: new trials by email Literature Review of Eye Infections, Fungal trials Research Report on Eye Infections, Fungal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Voriconazole, Placebo - Corneal Ulcer, Eye Infections, Fungal
Phase 3CompletedUniversity of California, San Francisco2402010-05-012019-02-26
Mycotic Ulcer Treatment Trial I
Natamycin, Voriconazole - Corneal Ulcer, Eye Infections, Fungal
Phase 3CompletedUniversity of California, San Francisco3232010-04-012018-08-01
Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
Natamycin 5%, Voriconazole, Corneal de-epithelialization - Fungal Keratitis
Phase 1 / Phase 2CompletedUniversity of California, San Francisco1202007-11-012018-08-07

Narrower conditions

Corneal Ulcer (2)  ·  Eye Diseases (2)  ·  Mycoses (2)  ·  Keratitis (1)

Broader conditions

Bacterial Infections and Mycoses (3)  ·  Corneal Diseases (3)  ·  Eye Infections (3)  ·  Infections (3)  ·  Keratitis (2)  ·  Eye Diseases (1)  ·  Mycoses (1)

Interventions

Voriconazole (3)  ·  Natamycin (1)

Sponsors

University of California, San Francisco (3)

Countries

India (3)  ·  United States (2)  ·  Nepal (1)

Top investigators

NV Prajna, DNB, FRC Ophth (2)  ·  Nisha Acharya, MD, MS (2)  ·  Tom Lietman, MD (2)  ·  N V Prajna, MD (1)  ·  Nisha Acharya, MD MS (1)  ·  Thomas M Lietman, MD (1)

Results publications

PMID 20547942, PMID 23702779, PMID 25764482, PMID 26531051, PMID 27054515, PMID 27787540, PMID 28426856, PMID 28817744, PMID 35024776, PMID 40372030

NIH funding

U10EY018573 (2)